ArticleAnnals of hematology2023

Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme.

Lu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.